Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Eribaxaban for VTE prevention in total knee replacement
NCT00306254Phase 2Completed
- Sponsor
- Pfizer
- Start
- Mar 2006
- Modality
- Small Molecules
- Countries
- 16
01
Overview
A Phase 2 trial of Eribaxaban in venous thromboembolism (VTE), sponsored by Pfizer. Started Mar 2006; status: completed.
02
Drugs
Eribaxaban
03
Conditions
venous thromboembolism (VTE)
Beyond the preview
Go deeper on NCT00306254.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00306254.